Khalid Usman, Mujeeb ur Rehman, Arif Mumtaz, Naseeb UrRehman, & Salman Khan. (2021). EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION. Journal of Population Therapeutics and Clinical Pharmacology, 28(2), 418–422. https://doi.org/10.53555/jptcp.v28i2.6807